At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
DAC Danaos
Market Closed 07-10 16:00:00 EDT
128.39
+1.06
+0.83%
盘后128.39
+0.000.00%
16:10 EDT
High128.90Low126.82Vol89.21K
Open127.60D1 Closing127.33Amplitude1.63%
Mkt Cap2.34BTradable Cap1.08BTotal Shares18.20M
T/O11.39MT/O Rate1.06%Tradable Shares8.41M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Danaos Keeps Quarterly Dividend of $0.90 per Share, Payable on July 30 to Holders of Record on July 21.
MT Newswires Live  ·  07-06
Danaos Keeps Quarterly Dividend of $0.90 per Share, Payable on July 30 to Holders of Record on July 21.
Press Release: Danaos Corporation Declares Quarterly Dividend on Its Common Stock for the Second Quarter of 2026
Dow Jones  ·  07-06
Press Release: Danaos Corporation Declares Quarterly Dividend on Its Common Stock for the Second Quarter of 2026
Danaos sets annual shareholder meeting
Reuters  ·  06-18
Danaos sets annual shareholder meeting
Essential Performance and Real-time Control Without the Baggage
GlobeNewswire  ·  05-29
Essential Performance and Real-time Control Without the Baggage
Evaluating Danaos (DAC) After Recent Share Price Strength And Perceived Valuation Gap
Simply Wall St.  ·  05-27
Evaluating Danaos (DAC) After Recent Share Price Strength And Perceived Valuation Gap
Danaos Earnings Call Highlights Profitability And Drybulk Strength
TIPRANKS  ·  05-13
Danaos Earnings Call Highlights Profitability And Drybulk Strength
Gyre Therapeutics Announces NMPA Acceptance of New Drug Application for F351 (hydronidone) for CHB-Induced Liver Fibrosis Treatment
GlobeNewswire  ·  05-13
Gyre Therapeutics Announces NMPA Acceptance of New Drug Application for F351 (hydronidone) for CHB-Induced Liver Fibrosis Treatment
C4 Therapeutics Reports First Quarter 2026 Financial Results and Recent Business Highlights
GlobeNewswire  ·  05-12
C4 Therapeutics Reports First Quarter 2026 Financial Results and Recent Business Highlights
Danaos Corp reports results for the quarter ended March 31 - Earnings Summary
Reuters  ·  05-12
Danaos Corp reports results for the quarter ended March 31 - Earnings Summary
Danaos Q1 Adjusted Earnings, Revenue Rise
MT Newswires Live  ·  05-12
Danaos Q1 Adjusted Earnings, Revenue Rise
Greece's Danaos Q1 operating revenue flat, EPS rises
Reuters  ·  05-12
Greece's Danaos Q1 operating revenue flat, EPS rises
Danaos Q1 Adj. EPS $6.72 Beats $6.69 Estimate, Sales $253.698M Beat $251.488M Estimate
Benzinga  ·  05-12
Danaos Q1 Adj. EPS $6.72 Beats $6.69 Estimate, Sales $253.698M Beat $251.488M Estimate
Danaos Q1 FY26 net income rises 21.9% to USD 140.42 million
Reuters  ·  05-12
Danaos Q1 FY26 net income rises 21.9% to USD 140.42 million
Gyre Therapeutics Reports First Quarter 2026 Results and Provides Business Update
GlobeNewswire  ·  05-07
Gyre Therapeutics Reports First Quarter 2026 Results and Provides Business Update
Earning Preview: Danaos Q1 revenue is expected to decrease by 1.70%, and institutional views are constructive
Earnings Agent  ·  05-05
Earning Preview: Danaos Q1 revenue is expected to decrease by 1.70%, and institutional views are constructive
Danaos updates financial calendar for quarterly results release, earnings call and webcast
Reuters  ·  05-04
Danaos updates financial calendar for quarterly results release, earnings call and webcast
Danaos upgraded to Buy from Hold at Fearnley
TIPRANKS  ·  04-30
Danaos upgraded to Buy from Hold at Fearnley
Shipping News: 6 Plays on Rising Freight Rates -- Barron's
Dow Jones  ·  04-25
Shipping News: 6 Plays on Rising Freight Rates -- Barron's
War Has Sent Shipping Rates Soaring. 6 Stocks That Could Win, According to This Analyst. -- Barrons.com
Dow Jones  ·  04-23
War Has Sent Shipping Rates Soaring. 6 Stocks That Could Win, According to This Analyst. -- Barrons.com
C4 Therapeutics Expands Roche Collaboration with New DAC Deal
TIPRANKS  ·  04-09
C4 Therapeutics Expands Roche Collaboration with New DAC Deal

Introduction

Company Name.
Danaos
Affiliated Markets:
NYSE
Listing Date:
--
Main Business:
Danaos Corporation, together with its subsidiaries, owns and operates containerships in Australia, Asia, Europe, and the United States. The company offers seaborne transportation services, such as chartering its vessels to liner companies. As of March 7, 2023, it had a fleet of 68 containerships aggregating 421,293 twenty-foot equivalent units in capacity. The company was formerly known as Danaos Holdings Limited and changed its name to Danaos Corporation in October 2005. Danaos Corporation was founded in 1963 and is based in Piraeus, Greece.
Issue price:
--